Lbmc Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Lbmc Investment Advisors, LLC

$1.26 Billion
Q4 2024

A detailed history of Lbmc Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lbmc Investment Advisors, LLC holds 7,885 shares of BMY stock, worth $440,219. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,885

Previous 8,004 1.49%

Holding current value

$440,219

Previous $414,000 7.49%

% of portfolio

0.04%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$51.92 - $59.94 $6,178 - $7,132	-119 Reduced 1.49%	7,885 $445,000
Q3 2024 Oct 08, 2024	BUY	$39.66 - $51.75 $237 - $310	6 Added 0.08%	8,004 $414,000
Q2 2024 Jul 11, 2024	BUY	$40.25 - $52.99 $241 - $317	6 Added 0.08%	7,998 $332,000
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $29,651 - $33,619	618 Added 8.38%	7,992 $433,000
Q4 2023 Jan 16, 2024	SELL	$48.48 - $57.85 $5,672 - $6,768	-117 Reduced 1.56%	7,374 $378,000
Q3 2023 Oct 05, 2023	SELL	$57.89 - $64.73 $173 - $194	-3 Reduced 0.04%	7,491 $434,000
Q2 2023 Jul 17, 2023	BUY	$63.71 - $70.74 $637 - $707	10 Added 0.13%	7,494 $479,000
Q1 2023 Apr 10, 2023	BUY	$65.71 - $74.53 $591 - $670	9 Added 0.12%	7,484 $518,000
Q4 2022 Jan 10, 2023	BUY	$68.48 - $81.09 $547 - $648	8 Added 0.11%	7,475 $0
Q3 2022 Oct 07, 2022	BUY	$0.13 - $76.84 $0 - $230	3 Added 0.04%	7,467 $531,000
Q2 2022 Jul 07, 2022	BUY	$72.62 - $79.98 $217 - $239	3 Added 0.04%	7,464 $575,000
Q1 2022 Apr 11, 2022	BUY	$61.48 - $73.72 $245 - $294	4 Added 0.05%	7,461 $545,000
Q4 2021 Mar 17, 2022	BUY	$53.63 - $62.52 $321 - $375	6 Added 0.08%	7,457 $465,000
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $74,477 - $81,106	1,203 Added 19.25%	7,451 $498,000
Q1 2021 Apr 20, 2021	SELL	$59.34 - $66.74 $9,494 - $10,678	-160 Reduced 2.5%	6,248 $394,000
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $5,774 - $6,543	100 Added 1.59%	6,408 $398,000
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $172 - $190	3 Added 0.05%	6,308 $380,000
Q2 2020 Jul 14, 2020	SELL	$54.82 - $64.09 $1,754 - $2,050	-32 Reduced 0.5%	6,305 $371,000
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $1,716 - $2,494	37 Added 0.59%	6,337 $353,000
Q4 2019 Jan 22, 2020	BUY	$49.21 - $64.19 $147 - $192	3 Added 0.05%	6,300 $404,000
Q3 2019 Oct 24, 2019	BUY	$42.77 - $50.71 $171 - $202	4 Added 0.06%	6,297 $319,000
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $133 - $148	3 Added 0.05%	6,293 $285,000
Q1 2019 Apr 26, 2019	SELL	$45.12 - $53.8 $2,887 - $3,443	-64 Reduced 1.01%	6,290 $300,000
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $3,071 - $3,983	-63 Reduced 0.98%	6,354 $330,000
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $441 - $498	8 Added 0.12%	6,417 $398,000
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $10,510 - $13,099	208 Added 3.35%	6,409 $355,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $25,406 - $29,247	-424 Reduced 6.4%	6,201 $392,000
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $397,102 - $432,943	6,625	6,625 $406,000

Others Institutions Holding BMY

# of Institutions

2,751

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lbmc Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lbmc Investment Advisors, LLC with notifications on news.

Account

Lbmc Investment Advisors, LLC Bristol Myers Squibb CO Transaction History